CATALOGO DEI PRODOTTI DELLA RICERCA

BENCIVENGA, Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.219
EU - Europa 4.423
AS - Asia 3.415
SA - Sud America 535
Continente sconosciuto - Info sul continente non disponibili 201
AF - Africa 169
OC - Oceania 14
Totale 13.976
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.058
RU - Federazione Russa 2.067
SG - Singapore 1.345
CN - Cina 899
GB - Regno Unito 561
IT - Italia 556
BR - Brasile 423
VN - Vietnam 378
HK - Hong Kong 288
SE - Svezia 225
IE - Irlanda 223
DE - Germania 219
FR - Francia 189
KR - Corea 116
FI - Finlandia 115
BD - Bangladesh 86
CA - Canada 85
JP - Giappone 64
UA - Ucraina 50
ES - Italia 48
AR - Argentina 40
IN - India 39
NL - Olanda 38
ID - Indonesia 35
MX - Messico 35
ZA - Sudafrica 33
AT - Austria 31
TG - Togo 24
IQ - Iraq 22
NG - Nigeria 22
RW - Ruanda 22
BJ - Benin 20
PL - Polonia 20
IL - Israele 18
TR - Turchia 18
BE - Belgio 16
EC - Ecuador 16
AU - Australia 13
UZ - Uzbekistan 13
CO - Colombia 12
LT - Lituania 12
PK - Pakistan 12
PY - Paraguay 12
CL - Cile 10
VE - Venezuela 10
PH - Filippine 9
DZ - Algeria 8
HN - Honduras 8
JO - Giordania 8
AE - Emirati Arabi Uniti 7
CR - Costa Rica 7
JM - Giamaica 7
KG - Kirghizistan 7
PT - Portogallo 7
SA - Arabia Saudita 7
TW - Taiwan 7
EG - Egitto 6
GR - Grecia 6
KE - Kenya 5
MA - Marocco 5
MY - Malesia 5
NO - Norvegia 5
PE - Perù 5
TH - Thailandia 5
UY - Uruguay 5
AZ - Azerbaigian 4
BG - Bulgaria 4
CH - Svizzera 4
DO - Repubblica Dominicana 4
LB - Libano 4
LV - Lettonia 4
TN - Tunisia 4
AL - Albania 3
AO - Angola 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
EU - Europa 3
HU - Ungheria 3
LK - Sri Lanka 3
SC - Seychelles 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
XK - ???statistics.table.value.countryCode.XK??? 3
CG - Congo 2
CM - Camerun 2
ET - Etiopia 2
IR - Iran 2
KH - Cambogia 2
KZ - Kazakistan 2
LU - Lussemburgo 2
NI - Nicaragua 2
NP - Nepal 2
OM - Oman 2
PA - Panama 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
AM - Armenia 1
BB - Barbados 1
BF - Burkina Faso 1
Totale 13.759
Salva come PNG Salva come JPEG
Città #
Ashburn 769
Singapore 715
Moscow 697
San Jose 586
Dallas 433
Southend 413
Chandler 407
Hong Kong 282
Verona 277
Council Bluffs 222
Dublin 219
Beijing 178
Jacksonville 159
The Dalles 153
New York 143
Los Angeles 131
Ho Chi Minh City 126
Ann Arbor 93
Redmond 78
Houston 74
Woodbridge 74
Hanoi 71
Munich 70
Princeton 63
Lawrence 62
Helsinki 61
Tokyo 58
Jinan 56
Santa Clara 55
São Paulo 50
Wilmington 49
Nanjing 45
Buffalo 42
Shenyang 38
London 37
Milan 37
Columbus 34
Redondo Beach 33
Atlanta 32
Seoul 30
Hebei 27
Sindelfingen 27
Tianjin 26
Amsterdam 24
Dong Ket 24
Lomé 24
Orem 23
Frankfurt am Main 22
Jakarta 22
Kigali 22
Phoenix 22
Abuja 21
Chicago 21
Denver 21
Guangzhou 21
Seattle 21
Brooklyn 20
Changsha 20
Cotonou 20
Montreal 20
San Francisco 20
Toronto 19
Johannesburg 18
Vienna 18
Haikou 17
Brussels 16
Falls Church 16
Madrid 16
Mexico City 16
Stockholm 16
Lappeenranta 15
Nanchang 15
Nuremberg 15
Turku 15
Warsaw 15
Washington 15
Chennai 14
Haiphong 14
McKinney 14
Ningbo 14
Taizhou 14
Zhengzhou 14
Manchester 13
Belo Horizonte 12
Boston 12
Hangzhou 12
Paris 12
Rio de Janeiro 12
Rome 12
Jiaxing 11
Shanghai 11
Tashkent 11
Brasília 10
Da Nang 10
Fuzhou 10
Baghdad 9
Falkenstein 9
Poplar 9
Ankara 8
Biên Hòa 8
Totale 8.137
Salva come PNG Salva come JPEG
Nome #
Genomic characterization of hepatoid tumors: context matters 272
Proton Magnetic Resonance Spectroscopy: Ex vivo study to investigate its prognostic role in colorectal cancer. 236
High-throughput mutation profiling identifies novel molecular dysregulation in high-grade intraepithelial neoplasia and early gastric cancers 234
Shape and volume of internal anal sphincter showed by three-dimensional anorectal ultrasonography 221
Pretreatment Primary Tumor Stage is a Risk Factor for Recurrence in Patients with Esophageal Squamous Cell Carcinoma Who Achieve Pathological Complete Response After Neoadjuvant Chemoradiotherapy 220
Impact of super-extended lymphadenectomy on relapse in advanced gastric cancer. 216
A phase II trial of the FGFR inhibitor pemigatinib in patients with metastatic esophageal-gastric junction/gastric cancer trastuzumab resistant: the FiGhTeR trial 213
Extension of lymphadenectomy for gastric cancer:Audit at European specialist centres. 213
The amount of signet ring cells is significantly associated with tumour stage and survival in gastric poorly cohesive tumours 204
Molecular Analysis of an Intestinal Neuroendocrine/Non-neuroendocrine Neoplasm (MiNEN) Reveals MLH1 Methylation-driven Microsatellite Instability and a Monoclonal Origin: Diagnostic and Clinical Implications 204
Methylation Dynamics of RASSF1A and Its Impact on Cancer 201
Extranodal Extension of Nodal Metastases Is a Poor Prognostic Indicator in Gastric Cancer: a Systematic Review and Meta-analysis 199
Clinical pathways in gastric cancer care 199
Acute bleeding obstruction pancreatitis after Roux-en-Y anastomosis in total gastrectomy: a single center experience 193
Enhanced recovery after surgery protocol in patients undergoing esophagectomy for cancer: a single center experience 191
ASO Author Reflections: Recurrence After Pathological Complete Response in Esophageal Cancer: Analysis of Risk Factors for this Unexpected Event 191
One stage or two stage treatment of colorectal cancer associated to abdominal aortic aneurysm: morbidity and mortality. 186
Targeted therapies for advanced and metastatic adenocarcinoma of the gastroesophageal junction: is there something new? 186
Short-term and long-term risk factors in gastric cancer 185
Lymphadenectomy for gastric cancer at European specialist centres 183
Is there any role for super-extended limphadenectomy in advanced gastric cancer? results of an observational study from a western high volume center 180
TAK1-regulated expression of BIRC3 predicts resistance to preoperative chemoradiotherapy in oesophageal adenocarcinoma patients 179
A national survey on the current status of minimally invasive gastric practice on behalf of GIRCG 178
Do all the European surgeons perform the same D2? The need of D2 audit in Europe 169
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in multimodal therapy for patients with oligometastatic peritoneal gastric cancer: a randomized multicenter phase III trial PIPAC VEROne 168
Conversion gastrectomy for stage IV unresectable gastric cancer: a GIRCG retrospective cohort study 167
Bidirectional Approach with PIPAC and Systemic Chemotherapy for Patients with Synchronous Gastric Cancer Peritoneal Metastases (GCPM) 165
Management of critically ill surgical patients Case reports 165
Poorly Cohesive Gastric Cancers Showing the Transcriptomic Hallmarks of Epithelial-Mesenchymal Transition Behave Aggressively 165
Clinical Features of Gastric Signet Ring Cell Cancer: Results from a Systematic Review and Meta-Analysis 163
Tailored treatment for signet ring cell gastric cancer 162
Current practice on the use of prophylactic drain after gastrectomy in Italy: the Abdominal Drain in Gastrectomy (ADiGe) survey 161
Complications after gastrectomy for cancer: Italian perspective 161
Western strategy for EGJ carcinoma 157
Gastric stump cancer after distal gastrectomy for benign disease: clinicopathological features and surgical outcomes. 157
Multicenter Study of Presentation, Management, and Postoperative and Long-Term Outcomes of Septegenerians and Octogenerians Undergoing Gastrectomy for Gastric Cancer 157
Lymphadenectomy: how to do it? 155
Personalized therapeutic strategies in HER2-driven gastric cancer 154
The amount of cells with Signet Ring Cell morphology has a prognostic impact in poorly cohesive gastric carcinoma 152
A therapeutic perspective for proliferative vitreoretinopathy based on the inhibition of epithelial-mesenchymal transition by miR-194 150
ASO Visual Abstract: Bidirectional Approach with PIPAC and Systemic Chemotherapy for Patients with Synchronous Gastric Cancer Peritoneal Metastases (GCPM) 149
hERG1 behaves as biomarker of progression to adenocarcinoma in Barrett's esophagus and can be exploited for a novel endoscopic surveillance 148
Robotic versus open Ivor-Lewis esophagectomy: A more accurate lymph node dissection without burdening the leak rate 146
Extended lymphadenectomy in elderly and/or highly co-morbid gastric cancer patients: A retrospective multicenter study 145
Clinical predictors of postoperative complications in the context of enhanced recovery (ERAS) in patients with esophageal and gastric cancer 144
Landscape of Druggable Molecular Pathways Downstream of Genomic CDH1/Cadherin-1 Alterations in Gastric Cancer 144
Perianastomotic drainage in Ivor-Lewis esophagectomy, does habit affect utility? An 11-year single-center experience 144
A Comprehensive PDX Gastric Cancer Collection Captures Cancer Cell-Intrinsic Transcriptional MSI Traits 143
Laparoscopic transhiatal suture and gastric valve as a safe and feasible treatment for Boerhaave's syndrome: an Italian single center case series study 143
Consequences of the COVID-19 pandemic on the diagnosis and treatment of gastric cancer in referral centers in Italy 143
An aggressive early gastric cancer: Kodama's PenA type 141
Limited Usefulness of 18F-FDG PET/CT in Predicting Tumor Regression After Preoperative Chemotherapy for Noncardia Gastric Cancer: The Italian Research Group for Gastric Cancer (GIRCG) Experience 137
Stage IV Gastric Cancer: The Surgical Perspective of the Italian Research Group on Gastric Cancer 135
Influence of Tumor Stroma on the Aggressiveness of Poorly Cohesive Gastric Carcinoma 133
Para-aortic lymphadenectomy in surgery for gastric cancer: current indications and future perspectives 133
YAP Activation Is Associated with a Worse Prognosis of Poorly Cohesive Gastric Cancer 132
Problems faced by evidence-based medicine in evaluating lymphadenectomy for gastric cancer 129
Multigene Panel Testing Increases the Number of Loci Associated with Gastric Cancer Predisposition 129
VEGFA Status as a Predictive Marker of Therapy Outcome in Metastatic Gastric Cancer Patients Following Ramucirumab-Based Treatment 128
Correction: International consensus on the management of metastatic gastric cancer: step by step in the foggy landscape 124
Turning left or right? A comparative analysis in adenocarcinomas of the esophagogastric junction according to the seventh AJCC TNM classification for cancers of the esophagus and stomach: experience in a Chinese single institution 123
Surgical treatment of hepatic metastases from gastric cancer 122
Beyond years: evaluating the impact of surgeon age on outcomes after gastric cancer surgery 120
Recurrence in node-negative advanced gastric cancer: Novel findings from an in-depth pathological analysis of prognostic factors from a multicentric series 120
Mucin expression in gastric- and gastro-oesophageal signet-ring cell cancer: results from a comprehensive literature review and a large cohort study of Caucasian and Asian gastric cancer 120
Reconstruction Techniques and Associated Morbidity in Minimally Invasive Gastrectomy for Cancer: Insights From the GastroBenchmark and GASTRODATA databases 118
Gastric Cancer Maximum Tumour Diameter Reduction Rate at CT Examination as a Radiological Index for Predicting Histopathological Regression after Neoadjuvant Treatment: A Multicentre GIRCG Study 115
Which gastric cancer patients could benefit from staging laparoscopy? A GIRCG multicenter cohort study 114
Preoperative or Perioperative Docetaxel, Oxaliplatin, and Capecitabine (GASTRODOC Regimen) in Patients with Locally-Advanced Resectable Gastric Cancer: A Randomized Phase-II Trial 113
Treatment of EGJ Cancer within or outside clinical trials: Does the setting matter? A monocentric prospective observational study 112
Genomic events stratifying prognosis of early gastric cancer 111
Validation of two prognostic models for recurrence and survival after radical gastrectomy for gastric cancer 110
A pragmatic approach improves the clinical management of stage IV gastric cancer: Comparison between the Meta-Gastro results and the GIRCG's retrospective series 107
Management, short and long-term outcomes in septegenerians and octegenerians undergoing gastrectomy for cancer 104
Palliation with a multimodality treatment including hypoxic pelvic perfusion for unresectable recurrent rectal cancer: outcomes based on a retrospective study 99
Looking for a strategy in treating peritoneal gastric cancer carcinomatosis: an Italian multicenter Gastric Cancer Research group's analysis 98
Unveiling the prognostic significance of malignant ascites in advanced gastrointestinal cancers: a marker of peritoneal carcinomatosis burden 97
Perioperative Outcomes in Open Versus Minimally Invasive Gastrectomy For Gastric Cancer: A European Multicenter Study Based on the GASTRODATA Registry 95
Prophylactic Total Gastrectomy: Techniques 94
Development and validation of a pretreatment nomogram to predict overall survival in gastric cancer 93
Definition, diagnosis and treatment of oligometastatic oesophagogastric cancer: A Delphi consensus study in Europe 91
The hERG1 Potassium Channel Behaves As Prognostic Factor In Gastric Dysplasia Endoscopic Samples 90
International consensus on the management of metastatic gastric cancer: step by step in the foggy landscape : Bertinoro Workshop, November 2022 89
Development and validation of pretreatment nomogram for disease-specific mortality in gastric cancer-A competing risk analysis 85
Definitions and treatment of oligometastatic oesophagogastric cancer according to multidisciplinary tumour boards in Europe 83
Validating a nodal regression system for gastric cancer: An ancillary cohort study of the GASTRODOC trial 83
European clinical practice guidelines for the definition, diagnosis, and treatment of oligometastatic esophagogastric cancer (OMEC-4) 82
Primary Tumor Resection for Metastatic Colorectal, Gastric and Pancreatic Cancer Patients: In Search of Scientific Evidence to Inform Clinical Practice 82
Targeting FGFR Pathway Is Not an Effective Therapeutic Strategy in Patients with Unselected Metastatic Esophagogastric Cancer Resistant to Trastuzumab 80
Association between ERAS protocol and major postoperative complications and reasons for non-compliance in patients with esophageal cancer 80
On the road to standardization of D2 lymph node dissection in a European population of patients with gastric cancer 74
International External Validation of Risk Prediction Model of 90-Day Mortality after Gastrectomy for Cancer Using Machine Learning 70
Optimized EGFR Blockade Strategies in EGFR Addicted Gastroesophageal Adenocarcinomas 69
Defining benchmarks for total and distal gastrectomy: global multicentre analysis 68
Oligometastatic Gastric Cancer: Clinical Data from the Meta-Gastro Prospective Register of the Italian Research Group on Gastric Cancer 65
Upper Gastrointestinal Bleeding 62
Textbook Neoadjuvant Outcome-Novel Composite Measure of Oncological Outcomes among Gastric Cancer Patients Undergoing Multimodal Treatment 55
Tremelimumab and durvalumab as neoadjuvant or non-operative management strategy of patients with microsatellite instability-high resectable gastric or gastroesophageal junction adenocarcinoma: the INFINITY study by GONO 45
The Role of Staging Laparoscopy in Stage IV Gastric Cancer Patients 39
Impact of postoperative complications on clinical outcomes after gastrectomy for cancer: multicentre study 38
Totale 13.797
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.936
article - articoli 50.165
book - libri 0
conference - conferenze 558
curatela - curatele 0
other - altro 712
patent - brevetti 0
selected - selezionate 0
volume - volumi 501
Totale 103.872
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022363 0 0 0 42 33 23 8 41 18 30 30 138
2022/20231.276 73 140 102 217 105 319 7 104 129 11 32 37
2023/2024848 17 58 57 97 65 168 40 47 16 75 151 57
2024/20252.055 94 97 93 343 103 69 163 123 279 172 164 355
2025/20266.825 414 326 428 1.200 1.736 421 635 394 548 420 155 148
2026/2027895 101 166 243 385 0 0 0 0 0 0 0 0
Totale 13.976